Clin2
NCT07809438Worth exploringRecruiting

Comparing PET scans for early Parkinson's detection

Prodromal Parkinson's Disease

Part of Brain & nervous system clinical trials.

This study tests two different PET scan resolutions to see which is better at detecting signs of early Parkinson's. It is for people who are already part of a Parkinson's research study and may help improve early diagnosis.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
25 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be part of the PPMI 015 sub study for early Parkinson's.
  • You must be able to give your own consent to participate.
  • You must not have any medical or psychiatric condition that would make participation unsafe.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07265596Recruiting· Phase 2
Brain Scan Study for Early Parkinson's Disease

This trial uses a special brain scan (PET scan) to look at early changes in people who have early signs of Parkinson's disease. The goal is to learn more about how Parkinson's develops over time.

New Haven, Connecticut
NCT07830654Recruiting· Phase 2
Pet scan for Parkinson's disease

This study tests a new PET scan tracer called [18F]AV-133 to see if it can track Parkinson's disease over time. The scan may help doctors better understand the disease, and you would be part of the PPMI research program.

New Haven, Connecticut
NCT07640555Recruiting· Early Phase 1
Brain imaging study for Parkinson's and related movement disorders

This research study tests a new type of brain scan (called a PET scan) that may help detect early signs of Parkinson's disease and similar conditions. You'll receive the scan and may have a spinal tap to check for specific protein markers.

New Haven, Connecticut
NCT06303921Recruiting· Early Phase 1
Study of a new brain imaging agent for Parkinson's disease

This trial uses a special PET scan to see how a new imaging agent (called 11C-M503) travels through the body and brain. It may help researchers better understand brain conditions like Parkinson's disease.

New Haven, Connecticut
NCT06098612Recruiting· Early Phase 1
PET imaging study for Parkinson's and related disorders

This study uses a new PET scan tracer called [11C]SY08 to take pictures of the brain in people with Parkinson's, multiple system atrophy, or dementia with Lewy bodies. It aims to see if this tracer can help better understand and tell apart these conditions.

Charlestown, Massachusetts
NCT07542158Enrolling by invitation· Phase 2
Ultra-Low Radiation PET Imaging Study for Brain Scanning

This study tests a new way to take brain imaging scans (PET scans) using a very small amount of radioactive tracer. Researchers want to see if they can get clear pictures of your brain while reducing your radiation exposure compared to standard scans.

Englewood, New Jersey

Hear when a new Prodromal Parkinsons Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.